angiotensin II blocker
Showing 1 - 25 of >10,000
Coarctation of Aorta, High Blood Pressure Trial in Rochester (Losartan, Amlodipine, Placebo)
Not yet recruiting
- Coarctation of Aorta
- High Blood Pressure
- Losartan
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Nov 21, 2023
Aortic Valve Stenosis, Valsartan, Angiotensin Receptor Antagonists Trial in Limoges (Valsartan, Placebo Oral Tablet)
Not yet recruiting
- Aortic Valve Stenosis
- +5 more
- Valsartan
- Placebo Oral Tablet
-
Limoges, FranceLimoges university hospital
Dec 23, 2022
Therapeutic Drug Use for CKD Patients
Active, not recruiting
- Chronic Kidney Disease
- angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, DPP-4 inhibitors, GLP-1 receptor agonists, SGLT2 inhibitors, calcium channel blockers, β Receptor blocker
-
Jinan, Shandong, ChinaXiao Li，MD
Apr 18, 2023
Cardiovascular Diseases, Hypertension Trial in San Francisco (Losartan, Placebo)
Recruiting
- Cardiovascular Diseases
- Hypertension
- Losartan
- Placebo
-
San Francisco, CaliforniaSan Francisco Veterans' Affairs Medical Center
Apr 29, 2022
AML, Acute Myeloid Leukemia Trial in Charlottesville (Cardioprotection)
Recruiting
- AML
- Acute Myeloid Leukemia
-
Charlottesville, VirginiaUniversity of Virginia
Jul 2, 2022
Pulmonary Hypertension Trial in Badalona (Sacubitril / Valsartan Oral Tablet [Entresto])
Completed
- Pulmonary Hypertension
- Sacubitril / Valsartan Oral Tablet [Entresto]
-
Badalona, Barcelona, SpainGermans Trias i Pujol University Hospital
Sep 23, 2021
Heart Failure Trial in Saga (Sacubitril Valsartan Sodium Hydrate, Standard treatment)
Recruiting
- Heart Failure
- Sacubitril Valsartan Sodium Hydrate
- Standard treatment
-
Saga, JapanSaga University Hospital
Dec 27, 2021
Idiopathic Membranous Nephropathy Trial in Aarhus (100 mg AP1189, Placebo)
Recruiting
- Idiopathic Membranous Nephropathy
- 100 mg AP1189
- Placebo
-
Aarhus, DenmarkAarhus Universitetshospital
Sep 21, 2021
Cognitively Normal Older Adults, Hypertension, Subjective Cognitive Decline Trial in United States (drug, behavioral, other)
Completed
- Cognitively Normal Older Adults
- +3 more
- Angiotensin II receptor blocker (ARB, losartan) and calcium channel blocker (CCB, amlodipine)
- +3 more
-
Kansas City, Kansas
- +3 more
Feb 12, 2022
Idiopathic Membranous Nephropathy Trial in Paris (symptomatic treatment (Converting Enzyme inhibitor, Angiotensin II,
Completed
- Idiopathic Membranous Nephropathy
- symptomatic treatment (Converting Enzyme inhibitor, Angiotensin II, Anti-renin, Aldosterone antagonist diuretic, Beta blocker, Calcium inhibitor, statin)
- experimental (Non Immunosuppressive Symptomatic Treatment (NIST) and Rituximab)
-
Paris, FranceDepartment of Nephrology , Tenon hospital - APHP
Oct 18, 2021
Diabetes, Cardiovascular Diseases Trial in Singapore (Renin-angiotensin-aldosterone system inhibitors, Beta blocker, SGLT2
Recruiting
- Diabetes Mellitus
- Cardiovascular Diseases
- Renin-angiotensin-aldosterone system inhibitors
- +2 more
-
Singapore, SingaporeSingapore General Hospital (SGH)
Apr 28, 2021
SARS-CoV-2, COVID-19 Trial in Austria, Germany (ACE inhibitor, angiotensin receptor blocker)
Completed
- SARS-CoV-2
- COVID-19
- ACE inhibitor, angiotensin receptor blocker
-
Innsbruck, Tyrol, Austria
- +30 more
Aug 18, 2022
Septic Shock, Shock, Sepsis Trial (Angiotensin II and hydrocortisone sodium succinate)
Not yet recruiting
- Septic Shock
- +3 more
- Angiotensin II and hydrocortisone sodium succinate
- (no location specified)
Nov 3, 2023
Septic Shock, Vasodilatory Shock Trial in Albuquerque (Angiotensin II)
Recruiting
- Septic Shock
- Vasodilatory Shock
- Angiotensin II
-
Albuquerque, New MexicoUniversity of New Mexico Health Sciences Center
Apr 19, 2023
Septic Shock, Acute Kidney Injury Trial in Lexington (Standard of Care, Angiotensin II)
Recruiting
- Septic Shock
- Acute Kidney Injury
- Standard of Care
- Angiotensin II
-
Lexington, KentuckyUniversity of Kentucky HealthCare Chandler Medical Center
Dec 7, 2022
Preeclampsia Postpartum Trial in Iowa City (Compound 21)
Recruiting
- Preeclampsia Postpartum
- Compound 21
-
Iowa City, IowaUniversity of Iowa
Jul 7, 2023
Acute Kidney Injury Trial (IRBESARTAN, tablet, 150 mg, Placebo, tablet, 150 mg)
Not yet recruiting
- Acute Kidney Injury
- IRBESARTAN, tablet, 150 mg
- Placebo, tablet, 150 mg
- (no location specified)
Aug 8, 2022
Hypertension Trial in London (Preoperative ACEi/ARB management)
Completed
- Hypertension
- Preoperative ACEi/ARB management
-
London, Ontario, CanadaLondon Health Sciences Centre
Oct 21, 2021
Myocardial Infarction With Non-obstructive Coronary Arteries Trial in Worldwide (Beta blocker, ACEI, ARB)
Recruiting
- Myocardial Infarction With Non-obstructive Coronary Arteries
- Beta blocker
- +2 more
-
Adelaide, Sout Australi, Australia
- +19 more
Sep 6, 2021
Liver Transplant; Complications, Vasoplegia Trial in San Francisco (Angiotensin II, Saline)
Recruiting
- Liver Transplant; Complications
- Vasoplegia
- Angiotensin II
- Saline
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jun 29, 2022
Obesity Trial in Hershey (Angiotensin-(1-7), Saline)
Recruiting
- Obesity
-
Hershey, PennsylvaniaPenn State Milton S. Hershey Medical Center
Dec 1, 2022
Aortic Dissection Trial in Beijing (No intervention)
Recruiting
- Aortic Dissection
- No intervention
-
Beijing, Beijing, ChinaAnzhen hospital, Beijing
Aug 1, 2022
COVID-19, SARS-CoV2 Infection Trial in India (Candesartan Cilexetil, Repagermanium, Candesartan Placebo)
Recruiting
- COVID-19
- SARS-CoV2 Infection
- Candesartan Cilexetil
- +3 more
-
Guntur, India
- +4 more
Mar 13, 2022
Heart Failure, Systolic Trial in Karachi (Sacubitril/valsartan)
Completed
- Heart Failure, Systolic
-
Karachi, Sindh, PakistanNational Institute of Cardiovascular Diseases
May 20, 2022